These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1691877)

  • 21. Differential subsensitivity of dopaminergic and neostriatal neurons to apomorphine with long-term treatment.
    Rebec GV; Lee EH
    Brain Res; 1982 Oct; 250(1):188-92. PubMed ID: 7139316
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of d-amphetamine on dopaminergic neurotransmission; a comparison between the substantia nigra and the striatum.
    Elverfors A; Nissbrandt H
    Neuropharmacology; 1992 Jul; 31(7):661-70. PubMed ID: 1328918
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Degeneration of dopaminergic neurons and free radicals. Possible participation of levodopa.
    Ogawa N; Edamatsu R; Mizukawa K; Asanuma M; Kohno M; Mori A
    Adv Neurol; 1993; 60():242-50. PubMed ID: 8380518
    [No Abstract]   [Full Text] [Related]  

  • 24. Controls for lesions of the nigrostriatal dopamine system.
    Robinson TE
    Science; 1991 Jul; 253(5017):332. PubMed ID: 1907023
    [No Abstract]   [Full Text] [Related]  

  • 25. The dopaminergic nigrostriatal system: development, physiology, disease.
    von Bohlen Und Halbach O; Krieglstein K; Schober A; Schulz JB
    Cell Tissue Res; 2004 Oct; 318(1):3. PubMed ID: 15340830
    [No Abstract]   [Full Text] [Related]  

  • 26. Does dopamine contribute to striatal damage caused by impaired mitochondrial function?
    Maragos WF; Jakel RJ; Chesnut MD; Geddes JW; Dwoskin LP
    Ann N Y Acad Sci; 1999; 893():345-9. PubMed ID: 10672263
    [No Abstract]   [Full Text] [Related]  

  • 27. [The role of nigroneostriatal dopamine in the transfer of corticofugal pulsation to caudal nuclei neurons in cats].
    Oleshko NN
    Dokl Akad Nauk SSSR; 1991; 320(4):1013-7. PubMed ID: 1786774
    [No Abstract]   [Full Text] [Related]  

  • 28. Dopaminergic sprouting in the rat striatum after partial lesion of the substantia nigra.
    Blanchard V; Anglade P; Dziewczapolski G; Savasta M; Agid Y; Raisman-Vozari R
    Brain Res; 1996 Feb; 709(2):319-25. PubMed ID: 8833770
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of penfluridol of dopamine-sensitive adenylate cyclase in corpus striatum and substantia nigra of rats.
    Seeber U; Kuschinsky K
    Experientia; 1976 Dec; 32(12):1558-9. PubMed ID: 191279
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Excitotoxicity of NMDA and kainic acid is modulated by nigrostriatal dopaminergic fibres.
    Chapman AG; Dürmuller N; Lees GJ; Meldrum BS
    Neurosci Lett; 1989 Dec; 107(1-3):256-60. PubMed ID: 2515501
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Muscarinic and nicotinic cholinergic mechanisms in the mesostriatal dopamine systems.
    Zhou FM; Wilson C; Dani JA
    Neuroscientist; 2003 Feb; 9(1):23-36. PubMed ID: 12580337
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Unilateral electrolytic lesions of the substantia nigra cause contralateral circling in rats.
    Schwartz WJ; Gunn RH; Sharp FR; Evarts EV
    Brain Res; 1976 Mar; 105(2):358-61. PubMed ID: 1260449
    [No Abstract]   [Full Text] [Related]  

  • 33. Inhibitory mechanisms in the substantia nigra and the dopamine pathway.
    Straughan DW; James TA
    Int J Neurol; 1979; 13(1-4):81-93. PubMed ID: 122391
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of systemic and intrastriatal injections of haloperidol on striatal dopamine and DOPAC concentrations in rats pretreated by section of nigrostriatal fibres.
    Wuerthele SM; Moore KE
    J Pharm Pharmacol; 1980 Jul; 32(7):507-10. PubMed ID: 6105192
    [No Abstract]   [Full Text] [Related]  

  • 35. Intrastriatal quinolinic acid injections protect against 6-hydroxydopamine-induced lesions of the dopaminergic nigrostriatal system.
    Venero JL; Romero-Ramos M; Revuelta M; Machado A; Cano J
    Brain Res; 1995 Feb; 672(1-2):153-8. PubMed ID: 7749737
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preservation of a functional nigrostriatal dopamine pathway by GDNF in the intrastriatal 6-OHDA lesion model depends on the site of administration of the trophic factor.
    Kirik D; Rosenblad C; Björklund A
    Eur J Neurosci; 2000 Nov; 12(11):3871-82. PubMed ID: 11069582
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Noradrenaline loss selectivity exacerbates nigrostriatal toxicity in different species of rodents.
    Fornai F; Bassi L; Bonaccorsi I; Giorgi F; Corsini GU
    Funct Neurol; 1997; 12(3-4):193-8. PubMed ID: 9218976
    [No Abstract]   [Full Text] [Related]  

  • 38. Basic FGF is present in dopaminergic neurons of the ventral midbrain of the rat.
    Cintra A; Cao YH; Oellig C; Tinner B; Bortolotti F; Goldstein M; Pettersson RF; Fuxe K
    Neuroreport; 1991 Oct; 2(10):597-600. PubMed ID: 1684518
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Striatal, pallidal, and pars reticulata evoked inhibition of nigrostriatal dopaminergic neurons is mediated by GABA(A) receptors in vivo.
    Paladini CA; Celada P; Tepper JM
    Neuroscience; 1999 Mar; 89(3):799-812. PubMed ID: 10199614
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Turning behavior induced by electrical stimulation of the nigro-neostriatal system of the rat.
    Arbuthnott GW; Ungerstedt U
    Exp Neurol; 1975 Apr; 47(1):162-72. PubMed ID: 164362
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.